OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
772657

Carilex Medical Inc

Medical Equipment, Supplies & DistributionVerified

Carilex Medical Inc maintains a debt-to-equity ratio of 0.59, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt. This suggests that the company may need to manage its cash flow carefully to meet short-term obligations. In terms of profitability, Carilex Medical Inc's operating cash flow of TWD 46,566,000 indicates positive cash generation from operations. However, the company's capital expenditure of TWD -10,523,000 suggests that it is not currently investing heavily in new long-term assets. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the operating cash flow suggests a degree of operational efficiency. Carilex Medical Inc's revenue is concentrated in the European, American, New Zealand, Australian, and Taiwan markets. The company does not disclose specific segment revenues, so it is unclear whether any particular region or product line dominates its earnings. The geographic exposure suggests that the company is subject to regulatory and economic conditions in these regions, which could affect its performance. The company's growth trajectory is not explicitly outlined in the provided data, but the absence of significant capital expenditure may indicate a focus on maintaining current operations rather than expanding aggressively. The outlook for the current and next fiscal years is not provided, so it is difficult to assess the company's future performance based on the available data. The risk assessment for Carilex Medical Inc indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is assessed as medium, which could be a concern if cash flow from operations is not sufficient to cover short-term obligations. The company's debt structure, with long-term debt of TWD 172,144,000, suggests that it has a manageable debt burden, but the negative net cash position indicates that it may need to manage its liquidity carefully. Recent events and filings for Carilex Medical Inc are not detailed in the provided data, so it is not possible to assess the company's recent performance or strategic direction based on this information.

30-day price · 7726-1.80 (-5.0%)
Low$32.25High$35.70Close$33.90As of15 May, 00:00 UTC
Profile
CompanyCarilex Medical Inc
Ticker7726.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Carilex Medical Inc designs, manufactures, and sells medical equipment, including therapeutic support surfaces and negative pressure wound therapy machines, primarily for markets in Europe, the United States, New Zealand, Australia, and Taiwan.

Classification. Carilex Medical Inc is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Carilex Medical Inc maintains a debt-to-equity ratio of 0.59, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt. This suggests that the company may need to manage its cash flow carefully to meet short-term obligations. In terms of profitability, Carilex Medical Inc's operating cash flow of TWD 46,566,000 indicates positive cash generation from operations. However, the company's capital expenditure of TWD -10,523,000 suggests that it is not currently investing heavily in new long-term assets. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the operating cash flow suggests a degree of operational efficiency. Carilex Medical Inc's revenue is concentrated in the European, American, New Zealand, Australian, and Taiwan markets. The company does not disclose specific segment revenues, so it is unclear whether any particular region or product line dominates its earnings. The geographic exposure suggests that the company is subject to regulatory and economic conditions in these regions, which could affect its performance. The company's growth trajectory is not explicitly outlined in the provided data, but the absence of significant capital expenditure may indicate a focus on maintaining current operations rather than expanding aggressively. The outlook for the current and next fiscal years is not provided, so it is difficult to assess the company's future performance based on the available data. The risk assessment for Carilex Medical Inc indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is assessed as medium, which could be a concern if cash flow from operations is not sufficient to cover short-term obligations. The company's debt structure, with long-term debt of TWD 172,144,000, suggests that it has a manageable debt burden, but the negative net cash position indicates that it may need to manage its liquidity carefully. Recent events and filings for Carilex Medical Inc are not detailed in the provided data, so it is not possible to assess the company's recent performance or strategic direction based on this information.
Key takeaways
  • Carilex Medical Inc has a moderate debt-to-equity ratio of 0.59, indicating a balanced capital structure.
  • The company generates positive operating cash flow, which is a positive sign for liquidity and operational efficiency.
  • The company's revenue is concentrated in several key international markets, which may expose it to regional economic and regulatory risks.
  • The company's liquidity risk is assessed as medium, and it has a low potential for dilution, which is favorable for shareholders.
  • The company is not currently investing heavily in new long-term assets, as indicated by its capital expenditure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$338.6M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$46.6M
CapEx-$10.5M
Free cash flow
Total assets
Total liabilities$243.0M
Total equity$290.9M
Cash & equivalents
Long-term debt$172.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash-$172.1M
Current ratio
Debt/Equity0.6
ROA
ROE
Cash conversion
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric7726Activity
Op margin13.3% medp25 5.9% · p75 13.5%
Net margin8.6% medp25 2.7% · p75 12.7%
Gross margin64.0% medp25 60.1% · p75 65.6%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-3.1%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity59.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 22:17 UTC#cf51eaa5
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 22:18 UTCJob: a066a584